These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The expansion of vector-borne diseases and the implications for blood transfusion safety: The case of West Nile Virus, dengue and chikungunya]. Paty MC Transfus Clin Biol; 2013 May; 20(2):165-73. PubMed ID: 23622840 [TBL] [Abstract][Full Text] [Related]
5. Emerging viral infections‑-a potential threat for blood supply in the 21st century. de Mendoza C; Altisent C; Aznar JA; Batlle J; Soriano V AIDS Rev; 2012; 14(4):279-89. PubMed ID: 23258302 [TBL] [Abstract][Full Text] [Related]
6. [Assessment of a transfusion emergent risk: the case of HEV]. Pillonel J; Gallian P; Sommen C; Couturier E; Piquet Y; Djoudi R; Laperche S; Transfus Clin Biol; 2014 Nov; 21(4-5):162-6. PubMed ID: 25267205 [TBL] [Abstract][Full Text] [Related]
7. Transfusion safety: Where are we today? Luban NL Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681 [TBL] [Abstract][Full Text] [Related]
8. [Ten years of nucleic acid testing: lessons and prospects]. Morel P Transfus Clin Biol; 2011 Apr; 18(2):133-9. PubMed ID: 21397544 [TBL] [Abstract][Full Text] [Related]
9. Reflections on the emergence of chikungunya virus in the United States: time to revisit a successful paradigm for the safety of blood-derived therapies. Farrugia A; Kreil TR Transfusion; 2015 Jan; 55(1):224-6. PubMed ID: 25582241 [No Abstract] [Full Text] [Related]
13. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium. Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008 [TBL] [Abstract][Full Text] [Related]
14. The potential of viral metagenomics in blood transfusion safety. Sauvage V; Gomez J; Boizeau L; Laperche S Transfus Clin Biol; 2017 Sep; 24(3):218-222. PubMed ID: 28694025 [TBL] [Abstract][Full Text] [Related]
15. [Orthopoxviruses: infections in humans. Position of the Blood Working Group of the Federal Ministry of Health]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):957-72. PubMed ID: 20853093 [No Abstract] [Full Text] [Related]
16. [Update on infectious risks associated with blood products]. Traineau R; Elghouzzi MH; Bierling P Rev Prat; 2009 Jan; 59(1):86-9. PubMed ID: 19253889 [TBL] [Abstract][Full Text] [Related]
17. First "themed issue" of Transfusion on thirty years of progress in blood safety since recognition of transfusion-associated AIDS. Busch MP; Ness PM Transfusion; 2013 Oct; 53(10 Pt 2):2357-8. PubMed ID: 24099405 [No Abstract] [Full Text] [Related]
18. The significance of the blood-borne viruses: blood banking and transfusion medicine. Sherwood WC Dev Biol Stand; 1993; 81():25-33. PubMed ID: 8174810 [TBL] [Abstract][Full Text] [Related]
19. [Relevance of safety measures to avoid HTLV transmission by transfusion in 2014]. Laperche S; Pillonel J Transfus Clin Biol; 2014 Nov; 21(4-5):167-72. PubMed ID: 25267203 [TBL] [Abstract][Full Text] [Related]